Does BOTULINUM TOXIN TYPE A Cause Onychomycosis? 265 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 265 reports of Onychomycosis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 7.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
265
Reports of Onychomycosis with BOTULINUM TOXIN TYPE A
7.1%
of all BOTULINUM TOXIN TYPE A reports
265
Deaths
262
Hospitalizations
How Dangerous Is Onychomycosis From BOTULINUM TOXIN TYPE A?
Of the 265 reports, 265 (100.0%) resulted in death, 262 (98.9%) required hospitalization, and 262 (98.9%) were considered life-threatening.
Is Onychomycosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 265 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Onychomycosis?
ADALIMUMAB (791)
METHOTREXATE (742)
RITUXIMAB (708)
TOCILIZUMAB (706)
ETANERCEPT (683)
INFLIXIMAB (630)
CERTOLIZUMAB PEGOL (629)
GOLIMUMAB (625)
ABATACEPT (615)
TOFACITINIB (601)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Onychomycosis Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE